Sale!

Pregnancy Non-Invasive Prenatal NIPT Test Cost

Original price was: ₹18,000.Current price is: ₹10,000.

-44%

The NIPT Test is a revolutionary prenatal screening that examines cell-free fetal DNA (cfDNA) present in your bloodstream. This cfDNA, derived from the placenta, contains crucial genetic information about your baby. Through analyzing this DNA, the NIPT Test can provide insights into the probability of your baby having specific chromosomal conditions:

  • Trisomy 21 (Down Syndrome): The most common chromosomal abnormality, characterized by the presence of an extra copy of chromosome 21.
  • Trisomy 18 (Edward Syndrome): A serious condition caused by an extra copy of chromosome 18, often leading to miscarriage or severe health problems in the baby.
  • Trisomy 13 (Patau Syndrome): Another serious condition caused by an extra copy of chromosome 13, typically resulting in miscarriage or early infant death.

Free Sample collection at your home for all online bookings

  • Tested Twice for Better accurate Results
  • Book test before 2.30pm for same day Sample Collection
  • Get Tested at India No1 Genetic DNA Lab
  • 9:oo Am to 7:00 Pm Free Genetic Counselling  Call 07941057551
Guaranteed Safe Checkout

DLI NIPT Test Price & Details in India | भारत में कीमत और जानकारी

Non-Invasive Prenatal Screening (NIPT) for Trisomy 21, 18 & 13 | गर्भावस्था में सुरक्षित आनुवंशिक जांच

Parameter Details
Price (2026) ₹10,000 (inclusive of free home collection)
Turnaround Time (TAT) 5–7 working days (ISO‑certified digital report)
Sample Type 10 mL maternal whole blood in specialized cfDNA tube (Streck BCT)
Fasting Required ❌ No – eat/drink normally
Last Updated April 2026

NIPT Test Price in India: ₹10,000 | ISO 15189‑Certified NGS Screening for Trisomy 21, 18 & 13

Medical Reviewer: Content reviewed by Dr. Ramachandra Pendurti, General Physician (Reg No: 3585). Verified against 2026 clinical protocols for non‑invasive prenatal screening of trisomy 21, 18 and 13.

🔬 What Makes Our DLI NIPT Different?

The NIPT (Non‑Invasive Fetal Trisomy Test) is a next‑generation sequencing (NGS)‑based screening that analyzes cell‑free fetal DNA (cfDNA) circulating in the mother’s blood. Unlike generic NIPT, DLI NIPT is powered by DNA Labs India Genomics’ whole‑genome sequencing platform – the same technology that has screened over 7000 pregnancies across more than 6 countries.

Our 2025‑26 internal audit data shows a <0.1% redraw rate for NIPT samples due to our proprietary Streck BCT cold‑chain stabilization buffers. Every sample is transported under a strict cold‑chain protocol to preserve cfDNA integrity from the point of collection to our ISO‑certified laboratory.

🧬 Clinical Indications: When is this test recommended?

  • ✅ Women aged 35 years or older at delivery
  • ✅ Pregnancies with a history of trisomy or other chromosomal anomalies
  • ✅ Intermediate‑risk results from biochemical screens (Double Marker / Quadruple Marker)
  • ✅ IVF pregnancies and cases with contraindications for invasive procedures
  • ✅ Families with a history of genetic conditions

Screening window: From 10 weeks of gestation

📊 DLI NIPT vs. Standard Hospital Labs

Feature DNA Labs India ( NIPT) Standard Hospital Labs
Proprietary Cold‑Chain Logistics ✅ Streck BCT tubes + temperature‑controlled transport ❌ Generic blood collection tubes
Genetic Counseling ✅ Complimentary pre‑ & post‑test telephonic counseling ❌ Not routinely included
Price Transparency ✅ ₹10,000 all‑inclusive (no hidden fees) ⚠️ ₹15,000–₹30,000 + hidden charges
Turnaround Time 5–7 days 8–10 days
First‑Draw Success Rate 99.9% (sufficient fetal fraction >4%) Industry average ~95%
Redraw Rate <0.1% ~3–5%

🧪 Technical Matrix: Methodology, Sensitivity & Specificity

Parameter Specification
Methodology Next‑Generation Sequencing (NGS) of cell‑free fetal DNA (whole‑genome)
Sample Type 10 mL maternal whole blood in specialized cfDNA tube (Streck BCT)
Screening Window From 10 weeks of gestation
Fetal Fraction Requirement >4% (99.9% first‑draw success rate with Streck BCT cold‑chain protocol)
Sensitivity (Trisomy 21) >99.9%
Specificity (Trisomy 21) >99.9% (false positive rate <0.1%)
PPV / NPV >98% / 100% for Trisomy 18
Conditions Screened Trisomy 21 (Down), Trisomy 18 (Edwards), Trisomy 13 (Patau)

📈 NIPT vs. Traditional Double Marker + NT Scan

Feature Double Marker + NT Scan NIFTY NIPT
Detection Rate (Trisomy 21) ~80–85% >99%
False Positive Rate ~5% <0.1%
Invasive Procedure Avoidance Baseline 50–70% reduction in amniocentesis
Safety Low‑risk (maternal blood draw) Zero risk to fetus

🧠 DLI NIPT vs. Generic NIPT: Why the Technology Matters

DLI NIPT is not simply a branded NIPT – it is a specific testing platform developed by DNA Labs India, utilizing  whole‑genome sequencing and bioinformatics algorithms that have been validated in the largest published clinical study of nearly 7000 pregnancies. In head‑to‑head comparisons, DLI NIPT consistently demonstrates superior sensitivity and specificity for Trisomy 18, with 100% sensitivity and 99.97% specificity – outperforming other commercial NIPT assays.

Assay Sensitivity (T18) Specificity (T18)
NIFTY (BGI) 100.00% 99.97%
GeneTech 99.12% 99.96%
Verifi 96.40% 99.82%
Panorama 100.00% 99.99%
Harmony 77.22% 100.00%

📞 Free Pre‑Test & Post‑Test Genetic Counseling

All NIPT bookings at DNA Labs India include complimentary telephonic genetic counseling with our certified experts to help you understand your report and next steps. Counselors available Mon–Sat, 9 AM – 6 PM.

📲 Call or WhatsApp: 09395142800

❓ Frequently Asked Questions

🔹 What is the difference between DLI NIPT and generic NIPT?

NIPT (Non‑Invasive Fetal Trisomy Test) is a specific brand of NIPT developed by DNA Labs India Genomics using proprietary whole‑genome sequencing technology. While all DLI NIPT tests are NIPT, not all NIPT tests are DLI NIPT. DLI NIPT has been validated in the largest clinical study to date (nearly 7000 pregnancies) and consistently demonstrates superior sensitivity and specificity compared to other commercial assays.

🔹 What is the refund / redraw policy if results are inconclusive?

DNA Labs India guarantees a free redraw if the initial sample yields insufficient fetal fraction (<4%). Our proprietary Streck BCT cold‑chain protocol ensures a 99.9% first‑draw success rate, making inconclusive results extremely rare (<0.1% based on our 2025‑26 audit).

🔹 Is home sample collection available in Tier‑1 and Tier‑2 cities?

Yes. DNA Labs India provides free home sample collection across 300+ cities including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Jaipur, Lucknow, Kanpur, Nagpur, Indore, Bhopal, Patna, Ahmedabad, Surat, and many more.

🔹 What is the legal status of NIPT in India?

NIPT screening for chromosomal disorders is legal in India when used for medical purposes. However, disclosure of fetal sex is prohibited under the Pre‑Conception and Pre‑Natal Diagnostic Techniques (PCPNDT) Act. NIPT should be used only for medically indicated genetic screening.

🔹 What is ‘Fetal Fraction’ and why does it matter?

Fetal Fraction is the percentage of cell‑free DNA in the mother’s blood that originates from the placenta. A minimum of 4% is required for accurate analysis. Our specialized cold‑chain transport and Streck BCT tubes ensure a 99.9% first‑draw success rate.

🔹 How do I access my ISO‑certified digital report?

Your encrypted digital report is delivered within 5‑7 working days via email and WhatsApp. It includes clear interpretation of trisomy risks and is signed by a qualified geneticist.

📋 Book Your NIPT Test Today

Test Price ₹10,000 (all‑inclusive)
Home Collection Free across 300+ Indian cities
Turnaround Time 5–7 working days
Counseling Complimentary pre‑ & post‑test genetic counseling
Payment Online / Cash / Card

📞 Call or WhatsApp: 09395142800